RASBURICASE
RASBURICASE is an active ingredient listed in 1 FDA drug label records from 1 manufacturers marketed mainly as human prescription drug products.
About RASBURICASE
RASBURICASE appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from Sanofi-Aventis U.S. LLC. Approved labelling for these products most frequently references: plasma uric, elitek indicated, initial management, acid levels, adult patients, leukemia lymphoma, solid tumor, receiving anticancer. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.
Main manufacturers
| Manufacturer | Products | Marketing type |
|---|---|---|
| Sanofi-Aventis U.S. LLC | 1 | HUMAN PRESCRIPTION DRUG |
FDA drug products containing RASBURICASE
| Brand name | Manufacturer | Type | Route | Dosage form |
|---|---|---|---|---|
| Elitek | Sanofi-Aventis U.S. LLC | HUMAN PRESCRIPTION DRUG |
Frequently asked questions
How many FDA drug products contain RASBURICASE?
1 FDA drug label records list RASBURICASE as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.
Which companies make RASBURICASE products?
The manufacturers with the most RASBURICASE label records are Sanofi-Aventis U.S. LLC. Generic and brand versions may be produced by different companies.
Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.
This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.